Related Experiment Video
Updated: Jun 18, 2026
08:47
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines
A Vogelgesang1, S Rosenberg, S Skrzipek
1Department of Neurology, University of Greifswald, Greifswald, Germany.
Acta Neurologica Scandinavica
|November 21, 2009
Summary
Mitoxantrone treatment for multiple sclerosis (MS) boosts TH2 cytokine production, specifically interleukin-4 (IL-4) and IL-5, in T cells. This immune modulation may explain its therapeutic benefits in progressive MS.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Mitoxantrone is a treatment for progressive multiple sclerosis (MS).
- Mitoxantrone exhibits both cytotoxic and immunomodulatory effects.
- Understanding mitoxantrone's impact on immune cell function is crucial for MS treatment.
Purpose of the Study:
- To investigate the effects of mitoxantrone on cytokine patterns in MS patients.
- To analyze changes in T-cell subsets and peripheral blood mononuclear cells (PBMCs) ex vivo.
- To compare short-term and long-term mitoxantrone treatment effects on immune responses.
Main Methods:
- Blood samples were collected from MS patients before and after mitoxantrone infusion.
- Peripheral blood mononuclear cells (PBMCs), CD4+, and CD8+ T cells were stimulated in vitro.
- Cytokine production (TH1, TH17, TH2 types) and T-cell proliferation were measured.
Main Results:
- Mitoxantrone treatment significantly increased the production of TH2 cytokines, IL-4 and IL-5, in CD4+ T cells within 18 days.
- Long-term mitoxantrone treatment further enhanced IL-4 and IL-5 secretion.
- No significant changes were observed in TH1, TH17, or other cytokines (IL-10, TNF-α), nor in T-cell proliferation.
Conclusions:
- Mitoxantrone treatment in MS enhances the inducibility of TH2-type cytokines.
- This enhancement of TH2 cytokines may contribute to the therapeutic efficacy of mitoxantrone in MS.
- The study highlights a specific immunomodulatory mechanism of mitoxantrone in MS treatment.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...